Clinical Trial Update: S1201: Combination Chemo for Patients W/Advanced or Metastatic Esophageal, Gastric, or Gastroesophageal Junction Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial update of S1201 evaluating combination chemotherapy for advanced or metastatic esophageal, gastric, or gastroesophageal junction adenocarcinoma; s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Adenocarcinoma of the Gastroesophageal Junction
• Esophageal Cancer
• Gastric Cancer

Snippet

Sponsor: SWOG Cancer Research Network | Conditions: Adenocarcinoma of the Gastroesophageal Junction, Esophageal Cancer | Phase 2 | Status: COMPLETED | Results posted: 2019-08-29